Prevalence of serum antibodies to hantaviruses in northern Sweden as measured by recombinant nucleocapsid proteins

Scandinavian Journal of Infectious Diseases

Volumn 29, Issue 4, 1997, Pages 349-354

  Ahlm, Clas ^a   Juto, Per ^a   Stegmayr, Birgitta ^a   Settergren, Bo ^b   Wadell, Göran ^a   Tärnvik, Arne ^a   Elgh, Fredrik ^a  

^a UMEÅ UNIVERSITY   (Sweden)

^b DANDERYD HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; RECOMBINANT PROTEIN; VIRUS ANTIBODY; VIRUS RNA;

ANTIBODY BLOOD LEVEL; ANTIBODY TITER; ARTICLE; CROSS REACTION; ENZYME LINKED IMMUNOSORBENT ASSAY; HANTAVIRUS; HUMAN; IMMUNOFLUORESCENCE TEST; MAJOR CLINICAL STUDY; PUUMALA VIRUS; SWEDEN; VIRUS NUCLEOCAPSID;

EID: 0030721699     PISSN: 00365548     EISSN: None     Source Type: Journal    
DOI: 10.3109/00365549709011829     Document Type: Article

References (26)

1. Lee HW, Johnson, KM. Laboratory-acquired infections with Hantaan virus, the etiologic agent of Korean hemorrhagic fever. J Infect Dis 146: 645-51, 1982.
2. Lundkvist Å, Niklasson B. Haemorrhagic fever with renal syndrome and other hantavirus infections. Rev Med Virol 4: 177-84, 1994.
3. Elgh F, Lundkvist Å, Alexeyev OA, Wadell G, Juto P. A major antigenic domain for the human humoral response to Puumala virus nucleocapsid protein is located at the aminoterminus. J Virol Meth 59: 161-72, 1996.
4. Elgh F, Linderholm M, Wadell G, Juto P. The clinical usefulness of a Puumalavirus recombinant nucleocapsid protein based enzyme-linked immunosorbent assay in the diagnosis of nephropathia epidemica as compared with an immunofluorescence assay. Clin Diagn Virol 6: 17-26, 1996.
5. Lundkvist Å, Hörling J, Niklasson B. The humoral response to Puumala virus infection (nephropathia epidemica) investigated by viral protein specific immunoassays. Arch Virol 130: 121-30, 1993.
6. Lundkvist Å, Vapalahti O, Plyusnin A, Brus Sjölander K, Niklasson B, Vaheri A. Characterization of Tula virus antigenic determinants defined by monoclonal antibodies raised against baculovirus-expressed nucleocapsid protein. Virus Res 45: 29-44, 1996.
7. Sheshberadaran H, Niklasson B, Tkachenko EA. Antigenic relationship between hantaviruses analysed by immunoprecipitation. J Gen Virol 69: 2645-51, 1988.
8. Jenison S, Yamada T, Morris C, Anderson B, Torrez Martinez N, Keller N, Hjelle B. Characterization of human antibody responses to Four Corner hantavirus infection among patients with hantavirus pulmonary syndrome. J Virol 68: 3000-6, 1994.
9. Lundkvist Å, Kallio-Kokko H, Brus Sjölander K, Lankinen B, Niklasson B, Vaheri A, Vapalahti O. Characterization of Puumala virus nucleocapsid protein: identification of B-cell epitopes and domains involved in protective immunity. Virology 216: 397-406, 1996.
10. Elgh F, Lundkvist Å, Alexeyev OA, Stenlund H, Avsic-Zupanc T, Hjelle B, et al. Serological diagnosis of hantavirus infections by an enzyme-linked immunosorbent assay based on the detection of immunoglobulin G and M responses to recombinant nucleocapsid proteins of five viral serotypes. J Clin Microbiol 35: 1120-30, 1997.
11. Niklasson B, LeDuc J. Epidemiology of nephropathia epidemica in Sweden. J Infect Dis 155: 269-76, 1987.
12. Settergren B, Juto P, Wadell G, Trollfors B, Norrby SR. Incidence and geographic distribution of serologically verified cases of nephropathis epidemica in Sweden. Am J Epidemiol 127: 801-7, 1988.
13. Niklasson B, Hörnfeldt B, Lundkvist Å, Björsten S, LeDuc J. Temporal dynamics of Puumala virus antibody prevalence in voles and of nephropathia epidemica incidence in humans. Am J Trop Med Hyg 53: 134-40, 1995.
14. Ahlm C, Linderholm M, Juto P, Stegmayr B, Settergren B. Prevalence of serum IgG antibodies to Puumala virus (haemorrhagic fever with renal syndrome) in northern Sweden. Epidemiol Infect 113: 129-36, 1994.
15. WHO MONICA Project Principle Investigators. The World Health Organization MONICA Project (Monitoring Trends and Determinants in Cardiovascular Disease): a major international collaboration. J Clin Epidemiol 41: 105-14, 1988.
16. Lee HW. Korean hemorrhagic fever. Prog Med Virol 28: 96-113, 1982.
17. Niklasson B, Tkachenko E, Ivanov AP, van der Groen G, Wiger D, Andersen HK, et al. Hemorrhagic fever with renal syndrome: evaluation of ELISA for detection of Puumala virus specific IgG and IgM. Res Virol 141: 637-48, 1990.
18. Settergren B, Ahlm C, Juto P, Niklasson B. Specific Puumala virus IgG half a century after haemorrhagic fever with renal syndrome. Lancet (ii): 338, 1991.
19. Niklasson B, Nyman L, Linde A, Grandien M, Dalrymple J. An epidemiological survey of nephropathia epidemica in Sweden. Scand J Infect Dis 15: 239-45, 1983.
20. Niklasson B, LeDuc J, Nyström K, Nyman L. Nephropathia epidemica: incidence of clinical cases and antibody prevalence in an endemic area of Sweden. Epidemiol Infect 99: 559-62, 1987.
21. Sommer A-I, Traavik T, Mehl R, Berdal BP, Dalrymple J. Hemorrhagic fever with renal syndrome (nephropathia epidemica) in Norway: seroepidemiology 1981-1985. Scand J Infect Dis 20: 267-74, 1988.
22. Brummer-Korvenkontio M, Henttonen H, Vaheri A. Hemorrhagic fever with renal syndrome in Finland: Ecology and virology of nephropathia epidemica. Scand J Infect Dis 14 Suppl 36: 88-91, 1982.
23. Hörling J, Lundkvist Å, Persson K, Mullaart M, Dzagurova T, Dekonenko A, et al. Detection and subsequent sequencing of Puumala virus from human specimens by PCR. J Clin Microbiol 33: 277-82, 1995.
24. Hörling J, Cheng Y, Plyusnin A, Persson K, Lehväslaiho H, Vaheri A, et al. Nucleotide and deduced amino acid sequences of the M and S genome segments of a Swedish Puumala virus isolate. Virus Res 39: 321-30, 1995.
25. Hörling J, Lundkvist Å, Jaarola M, Plyusnin A, Tegelström H, Persson K, et al. Distribution and genetic heterogeneity of Puumala virus in Sweden. J Gen Virol 77: 2555-62, 1996.
26. Hjelle B, Jenison SA, Goade DE, Green WB, Feddersen RM, Scott AA. Hantaviruses: Clinical, microbiologie, and epidemiologic aspects. Crit Rev Clin Lab Sci 32: 469-508, 1995.